Peptide synthesis refers to chemical synthesis of peptides that involves production of peptides through amide bond formation. Peptides are short chains of amino acid monomers linked by peptide bonds which serve as building blocks for many important biological molecules like proteins. The peptide synthesis market has gained importance owing to wide utilization of peptides in medicine and biotechnology. Peptides find applications as therapeutic drugs, diagnostic agents, research reagents and more. Technological advancements have increased productivity and efficacy of peptide synthesis methodologies like solid phase peptide synthesis and solution phase synthesis.
The global peptide synthesis market is estimated to be valued at US$ 490.58 Mn in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the peptide synthesis market are GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth.
The global Peptide Synthesis Market Trends provides various opportunities such as increased adoption of peptide-based therapeutics, expansion in contract manufacturing and growing R&D activities. Several market players are expanding geographically to strengthen their market presence. For instance, GenScript Biotech has established manufacturing sites and research centers across Asia, Europe and North America.
The market is also driven by increasing demand for customized peptides in biomedical research, growing aging population leading to chronic diseases and expansion of biotechnology and pharmaceutical industries. However, high capital investment and operation costs involved in peptide synthesis may restrain the market growth.
Market drivers – High usage of customized peptides in diagnostic and biomedical research is a major market driver. Increase in R&D activities related to peptidomics and proteomics is also propelling market growth.
Market restrain – High capital costs required for setting up peptide synthesis facilities and high operating expenses associated with synthesis equipment and purification processes can hamper peptide synthesis market expansion. Quality control and stability issues related to peptide production pose challenges.
Segment Analysis
The Peptide Synthesis Market Size And Trends is dominated by the custom peptide synthesis sub segment. Majority of research institutions and pharmaceutical companies are outsourcing their peptide requirements to contract manufacturing organizations as the in-house production of peptides involves high capital investment for equipment and infrastructure. Custom peptide synthesis service providers have the necessary technologies and expertise to produce peptides as per customer requirements in terms of peptide sequence, purity levels and quantities.
Global Analysis
The North America region currently dominates the peptide synthesis market with the highest market share. Availability of advanced research infrastructure and presence of key market players in the US and Canada driving the growth of the market in this region. Asia Pacific region is identified as the fastest growing market for peptide synthesis during the forecast period. Increasing investments by governments and private players in life science research and growing collaborations between global pharmaceutical companies and Asian contract research organizations supporting the market growth.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile